Skip to main content

Table 2 Patient selection criteria for accelerated partial breast irradiation (APBI)

From: Accelerated partial breast irradiation: advances and controversies

Organization

Age (years)

Tumor size (cm)

Lymph node status

LVSI

Margin

Multifocality

DCIS

Neoadjuvant therapy

Histology

ASTRO [15]

 Suitable

≥60

≤2

pN0 (i+/i−)

No

Negative (≥2 mm)

Clinically unifocal

None

None

IDC

 Cautionary

50–59

2.1–3.0

–

Limited/focal

Close (<2 mm)

Clinically unifocal

≤3 cm

–

ILC

 Unsuitable

<50

>3

≥pN1

Extensive

Positive

Multifocal

>3 cm

Used

–

ASBS [16]

≥45

≤3

N0

–

Negative

–

≤3 cm

–

IDC or DCIS

ABS [17]

≥50

≤3

N0

–

–

Unifocal

–

–

IDC

  1. LVSI lymphovascular space invasion, DCIS ductal carcinoma in situ, ASTRO American Society of Therapeutic Radiation Oncology, pNi pathologically positive node determined by immunohistochemistry with a size ≤ 0.2 mm, IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, – not mentioned, ASBS American Society of Breast Surgeons, ABS American Brachytherapy Society